Quality Use of Medicines Alliance

Taking a consortium approach for collective impact on national health topics

The Quality Use of Medicines Alliance is a unique consortium of health sector organisations representing quality use of medicines expertise, education providers, researchers, colleges, peak bodies, member-based organisations, and consumer groups. 

Through two new Australian Government Department of Health and Aged Care grants, the Alliance will deliver co-designed and complementary educational and health literacy resources for a national audience of both health professionals and consumers.

Over two years, this program will address safety and quality use of medicines issues across the management of atopic dermatitis and gout, the use of antidepressants, and oral anticoagulants in at-risk populations.

The Quality Use of Medicines Alliance consists of: 

• Medcast: a nationwide provider of independent education for a range of health professions 

• Health Care Consumers’ Association: a peak health consumer organisation working to improve the quality and safety of health care

• Arthritis Australia: the leading national arthritis charity supporting people living with all types of arthritis

• Eczema Support Australia: a national support network advocating for people living with eczema 

• Pharmaceutical Society of Australia: the national peak professional pharmacy body representing Australia’s 36,000 pharmacists across all sectors and specialisations 

• QUM Connect: a specialist consultancy with experience and expertise in creating and implementing quality use of medicines initiatives to improve health outcomes 

• Royal Australian College of General Practitioners: Australia’s largest professional general practice organisation responsible for maintaining standards for quality clinical practice, education and training, and research in Australian general practice 

• Wiser Healthcare: a research collaboration involving the Monash University, Bond University, University of Sydney, and the University of Wollongong with a special interest in research in the areas of rational test ordering and quality use of medicines. 

The Quality Use of Medicines Alliance will collaborate with a wide range of health and consumer organisations over two years until August 2025.